137 results
Page 5 of 7
20-F/A
y8g3ghs8n j8cxcyu
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-12.2
8mx6af5e uwmu5gv
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-12.1
tzm i4b5uy2ugex2j
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
b6129elsbrc6scfd45
6 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
a665s tc3
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.2
xwpoka8tuw gvmj
5 Mar 15
Current report (foreign)
12:00am
6-K
zz0bx
5 Mar 15
Current report (foreign)
12:00am
424B5
upnyzelr93b0b5c51jd
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
739gbx 0q
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
m6cv2
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
424B2
7jceczibaepv6xe
13 Jun 14
Prospectus for primary offering
12:00am
F-3
5z3 ms488j8mj0
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
wyxhl
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-1.1
w8el7vqe2tfv2wfz1z
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am